Strategies aiming at increasing levels of UCP1 in WAT have become of interest as reduced expression of brown adipocyte-enriched genes in WAT is associated with obesity and type 2 diabetes in humans [6-8]. This evidence concerns the gene UCP1 and obesity disorder.